StockData
Enanta Pharmaceuticals Inc logo

Enanta Pharmaceuticals Inc (ENTA) stock

ENTANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q4 FY2026, quarter ended Sep 30, 2026Last filing: 10-K on Nov 18, 2026Score 2/302% above fair value
$8.69−1.98 (-18.56%)

Close on Nov 17, 2026Market cap $253.10MP/E –Yield –

Enanta Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Enanta Pharmaceuticals's market cap was $337.79M on Nov 11, 2026, against $301.98M a year earlier. Over the last 5 years it ranged from $109.29M to $1.51B, with a median of $337.79M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$337.79M+0.2%
2025Dec 31, 2025$337.27M+174.3%
2024Dec 31, 2024$122.98M-37.9%
2023Dec 29, 2023$198.17M-79.5%
2022Dec 30, 2022$967.20M-36.1%
2021Dec 31, 2021$1.51B+79.0%
2020Dec 31, 2020$845.24M-30.6%
2019Dec 31, 2019$1.22B-11.4%
2018Dec 31, 2018$1.37B+22.4%
2017Dec 29, 2017$1.12B+75.9%
2016Dec 30, 2016$637.71M+3.2%
2015Dec 31, 2015$618.03M-34.6%
2014Dec 31, 2014$945.53M+93.3%
2013Dec 31, 2013$489.12M–

More Enanta Pharmaceuticals figures

See a number that looks wrong?